Frailty A49.9 A41 J22
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Case: The study will include patients aged above 65 years of age presenting to emergency department, infectious disease, internal medicine or geriatric hospital wards with bacteraemia and/or acute respiratory infection Informed consent form signed Control: The typical control patient will be of the same age (+/- 3 years, but aged above 65 years), same sex, without suspicion of infection and hospitalized during the past or upcoming month in the same centre. Informed consent form signed
Exclusion criteria
Exclusion criteria: • Bed-ridden or terminally ill patient (based upon a threshold of ADL: =2 TBD, or Clinical Frailty scale: =8) • Patients that refuse the 3- and 6-months follow-up phone call assessments • Patients that will not be able to answer the 3- and 6-months follow-up phone call assessments via a nurse • Patients with persistent hemiplegia (Stroke), blindness, full dementia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quantify the impact of acute respiratory infection (ARI) and bacteraemia on QoL (including frailty and autonomy) in 65+ aged population. | — |
Secondary
| Measure | Time frame |
|---|---|
| Describe the etiology of ARI and bacteremia in aged population Stratify the impact of ARI and bacteremia on QoL and frailty by different infectious diseases Stratify by different outcomes measures (autonomy, frailty, disability) Stratify by health care setting and country Morbidity and mortality evaluation following hospitalization. | — |
Countries
France, Germany, Italy, Spain
Contacts
Uniklinik Köln - Zentrum für Innere Medizin